Effect of a Traditional Dosage Form on the quality of life of the patents suffering from vitiligo and Comparison to a Marketed Preparation

Formulation and Clinical Trial of a Traditional Dosage Form for Skin Depigmentation and Comparison to a Marketed Preparation in Two Groups of Patients Suffering From Vitiligo

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201205029618N1

Enrollment

Registered

2012-08-27

Start date

2012-08-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. vitiligo, pinta

Interventions

Intervention 1: In the Intervention group the formulation under study is used twice a day as a camouflage for 40 days. Intervention 2: In the control group the marketed cosmetic product is used twice

Treatment - Drugs

In the Intervention group the formulation under study is used twice a day as a camouflage for 40 days

In the control group the marketed cosmetic product is used twice a day as a camouflage for 40 days

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: vitiligo patients from 20-60 yrs. Exclusion criteria: under any vitiligo treatments.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality of Life of Patients. Timepoint: before and after intervention in 10 day intervals to 40 days. Method of measurement: use of DLQI questionare.	—

Secondary

Measure	Time frame
Change of skin patches color. Timepoint: before and after intervention in 10 day intervals to 40 days. Method of measurement: imaging and use of the software.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAyda Hosseinkhani

Shiraz School of Pharmacy

hoseinkhan@sums.ac.ir+98 71 1242 4255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026